Aase syndrome
Aase Syndrome is a rare genetic disorder characterized by congenital anemia and certain joint and skeletal deformities. The syndrome was first identified in the early 1960s by the American pediatrician, Dr. Jon Morton Aase, leading to its nomenclature. Aase Syndrome is also known by other names, including Aase-Smith Syndrome II and Congenital Anemia and Triphalangeal Thumbs.
Symptoms and Characteristics[edit | edit source]
The hallmark features of Aase Syndrome include:
- Congenital Hypoplastic Anemia: A reduction in red blood cells present at birth, leading to fatigue, weakness, and pallor.
- Triphalangeal Thumbs: An unusual hand feature where the thumbs have three phalanges instead of the normal two.
- Skeletal Anomalies: These may include narrow shoulders, delayed closure of the bones of the skull, and other joint and skeletal malformations.
Other symptoms can vary widely among individuals but may include heart defects, cleft lip or palate, and growth retardation.
Causes[edit | edit source]
The exact cause of Aase Syndrome remains unclear, but it is believed to involve genetic mutations. It is thought to be inherited in an autosomal recessive pattern, which means both parents must carry a copy of the mutated gene to pass the disorder onto their children.
Diagnosis[edit | edit source]
Diagnosis of Aase Syndrome is primarily based on the physical symptoms and characteristics observed in the patient. Blood tests can reveal the presence of anemia, and genetic testing may help in identifying mutations associated with the syndrome. Prenatal diagnosis is possible through advanced genetic testing methods if there is a known risk of the syndrome in the family.
Treatment[edit | edit source]
There is no cure for Aase Syndrome, and treatment focuses on managing the symptoms and complications. For anemia, treatments may include iron supplements, corticosteroids, or blood transfusions in severe cases. Surgical interventions may be necessary to correct skeletal deformities or heart defects. Regular monitoring and supportive care are essential to address any developmental delays or other complications.
Prognosis[edit | edit source]
The prognosis for individuals with Aase Syndrome varies depending on the severity of the symptoms and the presence of associated complications. With appropriate medical and supportive care, many individuals can lead relatively normal lives.
Research Directions[edit | edit source]
Research into Aase Syndrome is ongoing, with efforts focused on understanding the genetic basis of the disorder and developing more effective treatments. Advances in genetic research may eventually provide new insights into the causes and mechanisms of the syndrome, leading to improved diagnostic and therapeutic options.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD